Wolff Wiese Magana LLC Spring Works Therapeutics, Inc. Transaction History
Wolff Wiese Magana LLC
- $146 Million
- Q4 2024
A detailed history of Wolff Wiese Magana LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 168 shares of SWTX stock, worth $6,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168
Previous 168
-0.0%
Holding current value
$6,293
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.3MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$268 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$210 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$130 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$123 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$112 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.34B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...